Annual ROE:
-26.84%+10.61%(+28.33%)Summary
- As of today, CLDX annual return on equity is -26.84%, with the most recent change of +10.61% (+28.33%) on December 31, 2024.
- During the last 3 years, CLDX annual ROE has fallen by -4.41% (-19.66%).
- CLDX annual ROE is now -123.62% below its all-time high of 113.63%, reached on December 31, 2007.
Performance
CLDX ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly ROE:
-26.94%-3.94%(-17.13%)Summary
- As of today, CLDX quarterly return on equity is -26.94%, with the most recent change of -3.94% (-17.13%) on June 30, 2025.
- Over the past year, CLDX quarterly ROE has increased by +1.88% (+6.52%).
- CLDX quarterly ROE is now -116.04% below its all-time high of 168.00%, reached on April 30, 1986.
Performance
CLDX Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
CLDX ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | +28.3% | +6.5% |
| 3Y3 Years | -19.7% | +2.6% |
| 5Y5 Years | +42.5% | +25.8% |
CLDX ROE Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | -19.7% | +28.3% | -23.4% | +39.7% |
| 5Y | 5-Year | -19.7% | +42.5% | -23.4% | +39.7% |
| All-Time | All-Time | -123.6% | +93.5% | -116.0% | +96.9% |
CLDX ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | -26.94%(-17.1%) |
| Mar 2025 | - | -23.00%(-5.3%) |
| Dec 2024 | -26.84%(+28.3%) | -21.84%(+11.7%) |
| Sep 2024 | - | -24.74%(+14.2%) |
| Jun 2024 | - | -28.82%(+16.7%) |
| Mar 2024 | - | -34.58%(+22.6%) |
| Dec 2023 | -37.45%(-24.3%) | -44.69%(-7.5%) |
| Sep 2023 | - | -41.58%(-18.9%) |
| Jun 2023 | - | -34.98%(-2.5%) |
| Mar 2023 | - | -34.14%(-12.7%) |
| Dec 2022 | -30.13%(-34.3%) | -30.29%(-12.3%) |
| Sep 2022 | - | -26.97%(+2.5%) |
| Jun 2022 | - | -27.66%(-17.1%) |
| Mar 2022 | - | -23.62%(+3.4%) |
| Dec 2021 | -22.43%(+43.1%) | -24.45%(+15.3%) |
| Sep 2021 | - | -28.85%(+7.9%) |
| Jun 2021 | - | -31.32%(+6.0%) |
| Mar 2021 | - | -33.32%(+4.6%) |
| Dec 2020 | -39.41%(+15.5%) | -34.94%(-8.1%) |
| Sep 2020 | - | -32.32%(+10.9%) |
| Jun 2020 | - | -36.29%(+21.3%) |
| Mar 2020 | - | -46.13%(+1.7%) |
| Dec 2019 | -46.66%(+44.4%) | -46.95%(-8.5%) |
| Sep 2019 | - | -43.27%(-14.2%) |
| Jun 2019 | - | -37.89%(+5.5%) |
| Mar 2019 | - | -40.10%(+60.2%) |
| Dec 2018 | -83.89%(-126.2%) | -100.70%(-17.0%) |
| Sep 2018 | - | -86.09%(+0.8%) |
| Jun 2018 | - | -86.79%(-4.9%) |
| Mar 2018 | - | -82.75%(-113.5%) |
| Dec 2017 | -37.08%(+19.9%) | -38.76%(+24.7%) |
| Sep 2017 | - | -51.44%(+1.3%) |
| Jun 2017 | - | -52.12%(+0.3%) |
| Mar 2017 | - | -52.29%(-3.1%) |
| Dec 2016 | -46.27%(+8.7%) | -50.71%(-3.9%) |
| Sep 2016 | - | -48.81%(-7.8%) |
| Jun 2016 | - | -45.29%(-9.4%) |
| Mar 2016 | - | -41.41%(-0.4%) |
| Dec 2015 | -50.70%(-14.1%) | -41.25%(+2.6%) |
| Sep 2015 | - | -42.36%(+0.5%) |
| Jun 2015 | - | -42.58%(+0.4%) |
| Mar 2015 | - | -42.76%(+3.8%) |
| Dec 2014 | -44.44%(-13.2%) | -44.46%(-4.5%) |
| Sep 2014 | - | -42.54%(+0.4%) |
| Jun 2014 | - | -42.69%(-3.4%) |
| Mar 2014 | - | -41.27%(+4.4%) |
| Dec 2013 | -39.25%(+45.4%) | -43.18%(+19.0%) |
| Sep 2013 | - | -53.31%(-2.2%) |
| Jun 2013 | - | -52.18%(+3.1%) |
| Mar 2013 | - | -53.87%(+16.5%) |
| Dec 2012 | -71.88%(-15.5%) | -64.55%(-3.9%) |
| Sep 2012 | - | -62.15%(-6.5%) |
| Jun 2012 | - | -58.35%(-0.4%) |
| Mar 2012 | - | -58.13%(+0.8%) |
| Dec 2011 | -62.23%(-1730.3%) | -58.57%(-355.4%) |
| Sep 2011 | - | -12.86%(-32.0%) |
| Jun 2011 | - | -9.74%(-4.2%) |
| Mar 2011 | - | -9.35%(-143.5%) |
| Dec 2010 | -3.40%(+95.7%) | -3.84%(+95.0%) |
| Sep 2010 | - | -76.72%(+14.7%) |
| Jun 2010 | - | -89.95%(+21.9%) |
| Mar 2010 | - | -115.11%(+34.3%) |
| Dec 2009 | -79.49%(+69.7%) | -175.19%(+37.0%) |
| Sep 2009 | - | -277.98%(-54.3%) |
| Jun 2009 | - | -180.11%(-21.3%) |
| Mar 2009 | - | -148.50%(+49.7%) |
| Dec 2008 | -261.95%(-330.5%) | -294.95%(+9.5%) |
| Sep 2008 | - | -325.96%(+11.3%) |
| Jun 2008 | - | -367.62%(+57.8%) |
| Mar 2008 | - | -871.48%(-866.9%) |
| Dec 2007 | 113.63%(+164.3%) | 113.63%(+114.4%) |
| Sep 2007 | - | -789.29%(-221.9%) |
| Jun 2007 | - | -245.20%(-16.8%) |
| Mar 2007 | - | -209.90%(-27.2%) |
| Dec 2006 | -176.78%(-189.6%) | -165.01%(-53.3%) |
| Sep 2006 | - | -107.65%(-32.7%) |
| Jun 2006 | - | -81.12%(-26.7%) |
| Mar 2006 | - | -64.04%(-3.8%) |
| Dec 2005 | -61.04% | -61.68%(-16.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2005 | - | -53.09%(-17.8%) |
| Jun 2005 | - | -45.05%(-16.5%) |
| Mar 2005 | - | -38.67%(-19.1%) |
| Dec 2004 | -39.81%(-2.6%) | -32.48%(-3.6%) |
| Sep 2004 | - | -31.35%(-4.6%) |
| Jun 2004 | - | -29.96%(+3.4%) |
| Mar 2004 | - | -31.02%(+22.4%) |
| Dec 2003 | -38.79%(-7.5%) | -39.97%(+0.7%) |
| Sep 2003 | - | -40.24%(-20.4%) |
| Jun 2003 | - | -33.41%(+7.6%) |
| Mar 2003 | - | -36.16%(+2.1%) |
| Dec 2002 | -36.10%(+21.3%) | -36.95%(+16.6%) |
| Sep 2002 | - | -44.28%(+21.9%) |
| Jun 2002 | - | -56.72%(-5.1%) |
| Mar 2002 | - | -53.97%(-10.4%) |
| Dec 2001 | -45.87%(+25.5%) | -48.88%(+22.1%) |
| Sep 2001 | - | -62.72%(-16.1%) |
| Jun 2001 | - | -54.00%(-17.9%) |
| Mar 2001 | - | -45.81%(-12.4%) |
| Dec 2000 | -61.60%(+1.5%) | -40.75%(+16.3%) |
| Sep 2000 | - | -48.70%(-14.3%) |
| Jun 2000 | - | -42.61%(-3.2%) |
| Mar 2000 | - | -41.28%(+6.2%) |
| Dec 1999 | -62.51%(+84.9%) | -44.01%(+20.0%) |
| Sep 1999 | - | -55.03%(+84.4%) |
| Jun 1999 | - | -353.20%(+4.8%) |
| Mar 1999 | - | -370.92%(+0.5%) |
| Dec 1998 | -412.99%(-245.5%) | -372.86%(+25.7%) |
| Sep 1998 | - | -501.97%(-243.2%) |
| Jun 1998 | - | -146.28%(-12.2%) |
| Mar 1998 | - | -130.43%(-10.1%) |
| Dec 1997 | -119.52%(-75.1%) | -118.44%(-13.4%) |
| Sep 1997 | - | -104.48%(-75.0%) |
| Jun 1997 | - | -59.71%(+21.4%) |
| Mar 1997 | - | -76.01%(-3.2%) |
| Dec 1996 | -68.25%(-38.8%) | -73.65%(-15.3%) |
| Sep 1996 | - | -63.88%(+15.7%) |
| Jun 1996 | - | -75.76%(-31.5%) |
| Mar 1996 | - | -57.61%(+1.3%) |
| Dec 1995 | -49.17%(+1.0%) | -58.37%(+29.1%) |
| Sep 1995 | - | -82.35%(-19.4%) |
| Jun 1995 | - | -68.97%(-18.3%) |
| Mar 1995 | - | -58.29%(-18.3%) |
| Dec 1994 | -49.68%(-56.4%) | -49.28%(-20.0%) |
| Sep 1994 | - | -41.08%(-3.0%) |
| Jun 1994 | - | -39.89%(-4.6%) |
| Mar 1994 | - | -38.13%(+2.5%) |
| Dec 1993 | -31.77%(-92.4%) | -39.12%(-8.7%) |
| Sep 1993 | - | -35.98%(-34.0%) |
| Jun 1993 | - | -26.86%(-10.3%) |
| Mar 1993 | - | -24.35%(-40.3%) |
| Dec 1992 | -16.51%(+39.0%) | - |
| Oct 1992 | - | -17.36%(+4.5%) |
| Jul 1992 | - | -18.17%(+11.8%) |
| Apr 1992 | - | -20.59%(+0.9%) |
| Apr 1992 | -27.06%(+6.5%) | - |
| Jan 1992 | - | -20.77%(+21.6%) |
| Oct 1991 | - | -26.50%(-2.4%) |
| Jul 1991 | - | -25.87%(+12.3%) |
| Apr 1991 | -28.94%(-211.2%) | -29.51%(-53.2%) |
| Jan 1991 | - | -19.26%(-60.0%) |
| Oct 1990 | - | -12.04%(-0.6%) |
| Jul 1990 | - | -11.97%(-37.6%) |
| Apr 1990 | -9.30%(+25.2%) | -8.70%(+33.6%) |
| Jan 1990 | - | -13.11%(+35.2%) |
| Oct 1989 | - | -20.24%(-21.4%) |
| Jul 1989 | - | -16.67%(+3.0%) |
| Apr 1989 | -12.43%(-2.1%) | -17.19%(-6.6%) |
| Jan 1989 | - | -16.13%(-15.4%) |
| Oct 1988 | - | -13.98%(-18.2%) |
| Jul 1988 | - | -11.83%(+43.5%) |
| Apr 1988 | -12.18%(+39.9%) | -20.93%(-81.4%) |
| Jan 1988 | - | -11.54%(-20.0%) |
| Oct 1987 | - | -9.62%(-11.2%) |
| Jul 1987 | - | -8.65%(-12.5%) |
| Apr 1987 | -20.25%(-129.8%) | -7.69%(-105.7%) |
| Jan 1987 | - | 136.00%(-12.8%) |
| Oct 1986 | - | 156.00%(-7.1%) |
| Jul 1986 | - | 168.00%(0.0%) |
| Apr 1986 | 68.00% | 168.00% |
FAQ
- What is Celldex Therapeutics, Inc. annual return on equity?
- What is the all-time high annual ROE for Celldex Therapeutics, Inc.?
- What is Celldex Therapeutics, Inc. annual ROE year-on-year change?
- What is Celldex Therapeutics, Inc. quarterly return on equity?
- What is the all-time high quarterly ROE for Celldex Therapeutics, Inc.?
- What is Celldex Therapeutics, Inc. quarterly ROE year-on-year change?
What is Celldex Therapeutics, Inc. annual return on equity?
The current annual ROE of CLDX is -26.84%
What is the all-time high annual ROE for Celldex Therapeutics, Inc.?
Celldex Therapeutics, Inc. all-time high annual return on equity is 113.63%
What is Celldex Therapeutics, Inc. annual ROE year-on-year change?
Over the past year, CLDX annual return on equity has changed by +10.61% (+28.33%)
What is Celldex Therapeutics, Inc. quarterly return on equity?
The current quarterly ROE of CLDX is -26.94%
What is the all-time high quarterly ROE for Celldex Therapeutics, Inc.?
Celldex Therapeutics, Inc. all-time high quarterly return on equity is 168.00%
What is Celldex Therapeutics, Inc. quarterly ROE year-on-year change?
Over the past year, CLDX quarterly return on equity has changed by +1.88% (+6.52%)